Achieve Announces Patent Granted in the U.S. for Novel Analogs of Cytisinicline for Use in CNS and Addiction Indications
Go back to Achieve Announces Patent Granted in the U.S. for Novel Analogs of Cytisinicline for Use in CNS and Addiction Indications| (NASDAQ: ACHV) | Delayed: 5.22 +0.21 (4.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.01 | 52 Week High | $ | |||
| Open | $5.02 | 52 Week Low | $ | |||
| Day High | $5.44 | P/E | N/A | |||
| Day Low | $4.91 | EPS | $ | |||
| Volume | 1,445,808 | |||||
